Florida Regulations 63M-2.036: Adverse Drug Events and Medication Errors
Current as of: 2024 | Check for updates
|
Other versions
(1) All youth shall be monitored routinely for adverse drug events, and potential adverse drug events, including medication errors.
(2) Nursing and facility staff shall be notified of potential adverse drug effects and drug interactions through the Medical Alert system.
(3) Licensed health care professional staff shall monitor each youth daily, prior to administering medications, for potential medication side effects. For instances where licensed health care professional staff are not onsite and non-licensed staff members assist youth with medication administration, see Fl. Admin. Code R. 63M-2.031(8)(h)
(4) Licensed health care professional staff shall document side effect monitoring on the MAR on at least a weekly basis.
(5) Each facility shall monitor and identify all medication errors.
(6) The Designated Health Authority or physician designee, and the facility superintendent or Program Director shall review the medication error reports at least every two weeks. These findings shall be reviewed and summarized during the quarterly Pharmacy and Therapeutics Committee CQI meetings as per Fl. Admin. Code R. 64B16-27.300
(7) The Designated Health Authority and Superintendent or Program Director shall review the Corrective Action Plan and analysis of the causative events pertaining to a medication error to determine any existing trends.
Rulemaking Authority Florida Statutes § 985.64(2). Law Implemented 985.64(2), 985.145, 985.18 FS. History-New 3-16-14.
(3) Licensed health care professional staff shall monitor each youth daily, prior to administering medications, for potential medication side effects. For instances where licensed health care professional staff are not onsite and non-licensed staff members assist youth with medication administration, see Fl. Admin. Code R. 63M-2.031(8)(h)
(4) Licensed health care professional staff shall document side effect monitoring on the MAR on at least a weekly basis.
(5) Each facility shall monitor and identify all medication errors.
(6) The Designated Health Authority or physician designee, and the facility superintendent or Program Director shall review the medication error reports at least every two weeks. These findings shall be reviewed and summarized during the quarterly Pharmacy and Therapeutics Committee CQI meetings as per Fl. Admin. Code R. 64B16-27.300
(7) The Designated Health Authority and Superintendent or Program Director shall review the Corrective Action Plan and analysis of the causative events pertaining to a medication error to determine any existing trends.
Rulemaking Authority Florida Statutes § 985.64(2). Law Implemented 985.64(2), 985.145, 985.18 FS. History-New 3-16-14.